Cucurbitacin B exhibits antitumor effects on CD133+ HepG2 liver cancer stem cells by inhibiting JAK2/STAT3 signaling pathway.

Autor: Xiaoli Wang, Yudi Bai, Xue Yan, Jin Li, Bingxue Lin, Linzhi Dai, Cheng Xu, Hua Li, Dong Li, Tai Yang, Tao Zhang
Zdroj: Anti-Cancer Drugs; Jun2021, Vol. 32 Issue 5, p548-557, 10p
Databáze: Complementary Index